Long Period Observation of Biochemical Survey and Ultrasonography in Thyroid Diseases and Subclinical Thyroid Diseases
1 other identifier
observational
532
0 countries
N/A
Brief Summary
Clinical and subclinical thyroid disease is usually used to describe patients with mild symptoms correlated to hyperthyroid or hypothyroid state. Therapeutic decision for clinical and subclinical thyroid dysfunction should be considered individually. But long term outcome for treatment of such functional and structural thyroid diseases had not been recorded delicately in Taiwan. Further investigations should be observed in the future.The purpose of this study is aiming for early prevention and detection the potential risk factors for thyroid diseases in Taiwan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2016
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 5, 2016
CompletedFirst Posted
Study publicly available on registry
August 16, 2016
CompletedStudy Start
First participant enrolled
August 19, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 26, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2024
CompletedAugust 12, 2022
August 1, 2022
9 months
August 5, 2016
August 11, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Long Period Observation of Biochemical survey and Ultrasonography in Thyroid Diseases and Subclinical Thyroid Diseases
The study was designed as prospective pattern, and the investigators enrolled new patients with hyperthyroidism/hypothyroidism/nodular goiter/thyroid cancer with long period follow-up, then record thyroid change of thyroid function after treatment of anti-thyroid drugs or thyroid hormone replacement; the clinical outcome of nodular goiter with serial fine needle aspiration cytology and the correlation with thyroid ultrasonography, with the volume/echogenicity/vascularity of nodular goiters. Try to find the correlation of outcome (including how long will the anti-thyroid drugs be stopped without thyroid ablation, the natural course of benign nodular goiters without operation; or thyroid cancer recurrence, thyroid cancer, lymph nodes metastasis or distant metastasis, with surgery/radioactive iodine ablation/target therapy) with regular follow-up in outpatient department via time-dependent manner at least 5 years.
5 years
Eligibility Criteria
Thyroid diseases, age between 20 to 80 years old, consecutive follow-up in outptient department, and we expected to enroll 800 patients in one year, and follow-up with observation for 5 years.
You may qualify if:
- Age 20-80 years old
- Thyroid diseases, including nodular goiter, hyperthyroidism, hypothyroidism and thyroid cancer (before or after operation), consecutive follow-up in outpatient department, and we expected to enroll 800 patients in one year, and follow-up with observation for 5 years.
You may not qualify if:
- N/A
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
CHIH-YUAN WANG, Doctor
Department of Internal Medicine, National Taiwan University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 5, 2016
First Posted
August 16, 2016
Study Start
August 19, 2016
Primary Completion
May 26, 2017
Study Completion
July 30, 2024
Last Updated
August 12, 2022
Record last verified: 2022-08